UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Helixmith’s antibody therapy shows efficacy in immunoglobulin kidney disease
A joint research team of Helixmith and Seoul National University College of...
by Shim Hyun-tai
|
2020-08-26 17:47
라인
Celltrion to begin P1 trial of antibody-drug on mild Covid-19 patients
Celltrion has begun recruiting mild Covid-19 patients for the Phase 1 clini...
by Shim Hyun-tai
|
2020-08-26 17:17
라인
HK inno.N, T&R Biofab to develop skin therapy using 3D tech
HK inno.N has teamed up with T&R Biofab to test the efficacy of its skin di...
by Shim Hyun-tai
|
2020-08-26 16:19
라인
Virus cases rebound above 300, pushing nation closer to tightest restrictions
Korea’s new Covid-19 cases climbed back above 300 Wednesday, stepping up pr...
by Shim Hyun-tai
|
2020-08-26 13:35
라인
CrystalGenomics’ anticancer candidate has FDA’s orphan drug status
CrystalGenomics said Monday that the U.S. Food and Drug Administration has ...
by Shim Hyun-tai
|
2020-08-25 17:07
라인
PharmAbcine, Samsung Biologics sign CDMO deal for antibody candidate
PharmAbcine, a bio company specializing in antibody therapies, said Tuesday...
by Shim Hyun-tai
|
2020-08-25 16:57
라인
Huons' eye drop wins Saudi’s regulatory nod
Huons' flagship eye drop product entered the Saudi Arabia market, signa...
by Shim Hyun-tai
|
2020-08-25 14:50
라인
New virus cases below 300 for 2nd day but spreads continue
Korea saw new Covid-19 cases of below 300 for the second day on Tuesday but...
by Shim Hyun-tai
|
2020-08-25 11:51
라인
HK inno.N publishes P3 trial results of drug on gastric ulcers
HK inno.N has published the results of phase 3 clinical trial of gastroesop...
by Shim Hyun-tai
|
2020-08-24 18:02
라인
Intron Bio secures new drug substance for bacterial pneumonia
Intron Biotechnology said Monday that it has secured a new drug substance, ...
by Shim Hyun-tai
|
2020-08-24 18:01
라인
Regulator OKs Pfizer’s cardiomyopathy drug Vyndamax
The Ministry of Food and Drug Safety has approved Pfizer's Vyndamax (in...
by Shim Hyun-tai
|
2020-08-24 16:12
라인
Genexine begins global P3 trial of anemia drug
Genexine said Monday that the company has begun administering its long-acti...
by Shim Hyun-tai
|
2020-08-24 16:12
라인
Despite fall in new virus cases, calls rise for tightest social distancing
New virus cases dropped below 300 on Monday, but epidemiological experts ca...
by Shim Hyun-tai
|
2020-08-24 15:42
라인
Korea at crossroads of nationwide epidemic, expands tighter restrictions to whole country
Korea’s new virus cases exceeded 300 for two consecutive days on Saturday, ...
by Shim Hyun-tai
|
2020-08-22 19:08
라인
Seoul using near 80% of Covid-19 sickbeds
Out of the 1,118 sickbeds for the Covid-19 patients in the Seoul metro regi...
by Shim Hyun-tai
|
2020-08-21 18:10
라인
Korea going all out to import, develop Covid-19 vaccines, treatments
As global competition heats up to secure the Covid-19 vaccines, the Korean ...
by Shim Hyun-tai
|
2020-08-21 16:06
라인
Daewoong to co-develop esophagitis drug for treating Covid-19
Daewoong Pharmaceutical signed an agreement with Institut Pasteur Korea (IP...
by Shim Hyun-tai
|
2020-08-20 18:41
라인
Korea speeds up developing coronavirus-related products
The government plans to accelerate the development of Covid-19 diagnostic k...
by Shim Hyun-tai
|
2020-08-20 17:58
라인
Three-digit daily viruses for a week, raising fears about 2nd round
Korea’s daily Covid-19 cases remained at three-digit figures for the seven ...
by Shim Hyun-tai
|
2020-08-20 14:56
라인
SNUBH team finds gene mutation causing stomach cancer within families
Researchers at Seoul National University Bundang Hospital (SNUBH) have foun...
by Shim Hyun-tai
|
2020-08-19 21:10
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top